> Details

Seidl, Elias; Schramm, Dirk; Schön, Carola; Reiter, Karl; Pawlita, Ingo; Kappler, Matthias; Reu‐Hofer, Simone; Hauck, Fabian; Albert, Michael; Griese, Matthias

Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long‐term bridging to hematopoietic stem cell transplantation

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long‐term bridging to hematopoietic stem cell transplantation
  • Contributor: Seidl, Elias; Schramm, Dirk; Schön, Carola; Reiter, Karl; Pawlita, Ingo; Kappler, Matthias; Reu‐Hofer, Simone; Hauck, Fabian; Albert, Michael; Griese, Matthias
  • imprint: Wiley, 2022
  • Published in: Pediatric Pulmonology
  • Language: English
  • DOI: 10.1002/ppul.25728
  • ISSN: 8755-6863; 1099-0496
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Pulmonary alveolar proteinosis (PAP) is defined by increased accumulation of surfactant in the alveolar space. PAP has been reported to be associated with a large number of clinical conditions and diseases. Whole lung lavages (WLLs) can be helpful to stabilize the clinical course of PAP until the underlying condition is identified, which may enable more specific treatment. Recently, heterozygous <jats:italic>OAS1</jats:italic> gain‐of‐function variants were described as cause in patients with infantile‐onset PAP combined with hypogammaglobulinemia.</jats:p></jats:sec><jats:sec><jats:title>Case presentation</jats:title><jats:p>At age 4 months, a female infant born to term was diagnosed with hypogammaglobulinemia and treated with monthly immunoglobulin injections. At age 15 months, the girl needed supplemental oxygen at night, and at age 18 months, also during the day. At age 2 years, PAP of unknown etiology was diagnosed by computed tomography scan and open lung biopsy. Subsequently, monthly WLLs were started, which stabilized the clinical course for over 2 years until a disease‐causing <jats:italic>OAS1</jats:italic> variant was diagnosed and the patient was successfully treated by hematopoietic stem cell transplantation (HSCT).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Here, we describe the successful management of a female patient with severe PAP caused by a heterozygous <jats:italic>OAS1</jats:italic> gain‐of‐function variant until a definitive diagnosis was made and cured by HSCT.</jats:p></jats:sec>